Illinois Cancer Specialists

What Illinois Cancer Specialists does

Illinois Cancer Specialists is a community-based medical oncology and hematology practice serving cancer and blood disorder patients across six locations in the Greater Chicago metropolitan area (Arlington Heights, Chicago Resurrection, Crystal Lake, Elgin, Hoffman Estates, and Niles). The practice employs 21 board-certified physicians and is supported by 251-500 total staff, offering more than 30 years of continuous service with over 400 years of combined physician experience. Service lines include chemotherapy, targeted therapy, hormone therapy, surgery coordination, hematology, and survivorship support, delivered alongside a set of integrated ancillaries.

The operating model is built around in-house ancillaries that capture revenue typically outsourced by community oncology practices. These include an ACR-accredited diagnostic imaging center with PET, CT, and combination PET/CT; a CLIA-registered high-complexity clinical laboratory with COLA accreditation (the Niles lab is managed and staffed by Quest Diagnostics); OncologyRx Care Advantage, a specialty pharmacy dispensing over 500 oral oncology prescriptions monthly with insurance verification and financial assistance; a Genetic Risk Assessment program for hereditary cancer syndromes; and a Nurse Navigator program staffed by oncology-certified nurses. Clinical trial access is provided through affiliations with US Oncology Research and the Sarah Cannon Research Institute, which together have contributed to approximately one-third of all FDA-approved cancer therapies.

The practice operates under a fee-for-service healthcare delivery model, billing Medicare and major commercial insurers including Aetna, BCBS of Illinois, Cigna, Humana, and UnitedHealthcare. It participates in value-based arrangements including the CMS Oncology Care Model and holds Blue Distinction Center for Cancer Care designation from Blue Cross Blue Shield of Illinois. Illinois Cancer Specialists is a member practice of The US Oncology Network, a community of 1,200+ independent physicians supported by McKesson Corporation, which provides shared infrastructure and clinical research access. Patient acquisition is driven primarily by physician referrals, the practice's website, and patient testimonials; no app, API, or public SDK is offered.

Name

Illinois Cancer Specialists

Legal name

Illinois Cancer Specialists

Website

https://illinoiscancerspecialists.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

251–500 employees

Short description

Illinois Cancer Specialists is a community-based medical oncology and hematology practice serving cancer and blood disorder patients across six locations in the Greater Chicago area, with 21 board-certified physicians delivering integrated treatment, imaging, pharmacy, and clinical trial access.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Care Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Oncology services
• Cancer treatment
• Hematology care
• Diagnostic imaging
• Specialty pharmacy

Headquarters

HQ city

Schaumburg

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Patient Care Services: Fee-for-service healthcare delivery for cancer treatment and hematology services. Revenue generated through insurance billing for consultations, chemotherapy, targeted therapy, diagnostic imaging, laboratory tests, and pharmacy services. Operates under value-based payment models with Blue Cross Blue Shield Blue Distinction Centers designation.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Illinois Cancer Specialists is a community-based medical oncology and hematology practice delivering comprehensive cancer care and blood disorder treatment across six locations in the Greater Chicago Area. The practice provides chemotherapy, targeted therapy, hormone therapy, surgery coordination, diagnostic imaging (PET/CT), laboratory services, specialty pharmacy, nurse navigation, genetic risk assessment, and clinical trial access.

Product overview

Illinois Cancer Specialists is a community-based oncology and hematology practice offering comprehensive cancer care services across six locations in the Chicago area. The practice operates as a unified medical oncology and hematology service with integrated support services including on-site specialty pharmacy, diagnostic imaging (PET/CT, CT), laboratory services, genetic risk assessment, and nurse navigation. Through its affiliation with The US Oncology Network and participation in Sarah Cannon Research Institute clinical trials, the practice provides access to cutting-edge treatments and investigational therapies. Patient-facing digital services include a Patient Portal and online Bill Pay system, while the OncologyRx Care Advantage specialty pharmacy handles oral cancer medications. The practice accepts Medicare and major commercial insurance plans and has achieved QOPI Certification and Blue Distinction Center recognition.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology

Quantifiable outcome

• Over 500 prescriptions dispensed monthly through integrated pharmacy
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• The US Oncology NetworkcoreStrategic or Co-development PartnerIllinois Cancer Specialists is a practice in The US Oncology Network, which unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients close to home. Through The Network, independent doctors form a community of shared expertise and resources dedicated to advancing local cancer care and delivering better patient outcomes.
• McKesson CorporationcoreStrategic or Co-development PartnerMcKesson Corporation supports The US Oncology Network. Coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients while McKesson focuses on the health of their practices.
• US Oncology ResearchcoreStrategic or Co-development PartnerIllinois Cancer Specialists participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies - approximately one-third of all cancer therapies approved by the FDA to date.
• Sarah Cannon Research Institute (SCRI)coreStrategic or Co-development PartnerIllinois Cancer Specialists offers clinical trials through Sarah Cannon Research Institute, one of the world's leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA.
• Quest DiagnosticssupportingTechnology or IntegrationThe Niles laboratory facility is managed and staffed by Quest Diagnostics, providing access to their diagnostic testing capabilities and laboratory expertise.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• US Oncology Network: The parent network of Illinois Cancer Specialists, unifying ~1,200 independent oncology physicians nationwide and providing back-office, contracting, and research infrastructure via McKesson. Comparable on operating model and contract economics but operates at vastly greater scale.

Direct peers

• OneOncology: PE-sponsored (TPG-affiliated) community oncology partnership platform offering shared services to independent practices. Directly comparable as an alternative affiliation/rollup model to The US Oncology Network that could compete for ICS's physician base.
• American Oncology Network (AON): PE-backed community oncology platform that partners with independent practices to provide practice management, oral-oncolytic pharmacy, lab, and research services — same operating model as a US Oncology Network affiliate like Illinois Cancer Specialists.
• Tennessee Oncology: Physician-owned community oncology/hematology practice with ~30+ clinics in Tennessee and northern Georgia offering similar integrated diagnostics, pharmacy, and clinical-trial services — a structural community-oncology comp.
• Regional Cancer Care Associates: Mid-Atlantic community oncology/hematology practice offering in-office chemotherapy, on-site labs, and clinical trials, with previous PE backing. Operates a substantially identical community-oncology service model to ICS across multiple sites.
• Florida Cancer Specialists & Research Institute: Largest independent community oncology practice in the U.S., with 100+ sites in Florida and the Carolinas. Directly comparable on physician-led community oncology, integrated dispensing, in-house imaging/lab, and broad clinical-trial participation through Sarah Cannon.
• Texas Oncology: Largest affiliate within The US Oncology Network, operating 200+ community-based oncology sites across Texas. Closest structural comp to Illinois Cancer Specialists: same network affiliation, same medically-integrated pharmacy/clinical-trial economics, same community-care model, and same McKesson back-office.

Others

• McKesson Corporation: Owner/operator of The US Oncology Network, Illinois Cancer Specialists' corporate parent, and one of the largest specialty oncology drug distributors. Comparable as the infrastructure/back-office enabler whose economics and contracting decisions directly shape ICS's margin profile.
• Sarah Cannon Research Institute: Community-based clinical-trial site network through which ICS delivers investigational oncology therapy. Comparable as a research-ecosystem participant that drives differentiation and incremental per-patient trial revenue for affiliated practices like ICS.

Regional players

• Compass Oncology: Pacific Northwest community oncology practice (Oregon/Washington) operating multiple sites with integrated diagnostics, infusion, and clinical-trial access through US Oncology Network — the same network affiliation as Illinois Cancer Specialists. Useful structural comp on service mix despite geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• Xx.com/ILCancerSpecial
• Facebookfacebook.com/OurOnlyCareIsYou
• LinkedInlinkedin.com/company/illinois-cancer-specialists

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Illinois Cancer Specialists